DLGAP5 and ovarian carcinoma: For example, Zhang et al. [12] found that DLGAP5 was remarkably upregulated in ovarian cancer and its higher expression was correlated with poorer prognosis for survival, while the inhibition of DLGAP5 resulted in suppressed cell proliferation, G2/M phase arrest and apoptosis induction in ovarian cancer [12].